Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
Stock Snapshot
With a market cap of 217.61B, Novo Nordisk(NVO) trades at $49.27. The stock has a price-to-earnings ratio of 14.25 and currently yields dividends of 2.5%.
On 2025-11-20, Novo Nordisk(NVO) stock moved within a range of $49.19 to $49.36. With shares now at $49.27, the stock is trading +0.2% above its intraday low and -0.2% below the session's peak.
Trading activity shows a volume of 162.31K, compared to an average daily volume of 20.91M.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $45.05.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $45.05.
NVO News
Novo Nordisk just addressed a problem that has prevented some from taking these drugs. Investors generally buy pharmaceutical stocks to add an element of safet...
Novo Nordisk is investing aggressively to improve its pipeline of drugs in development. Novo Nordisk (NVO +2.00%) stock is underperforming in 2025, and investo...
Denmark is heading for its worst year of job losses since the Covid pandemic, as sweeping cuts at pharmaceutical giant Novo Nordisk A/S drive a surge in redunda...
Analyst ratings
59%
of 32 ratingsMore NVO News
Key Points Weight loss pills could account for 25% of the market share over the long term. The GLP-1 market is expected to grow to $100 billion by 2030. New...
Novo Nordisk will cut the direct-to-consumer prices of Wegovy and Ozempic, bringing monthly costs for many cash-paying patients down to $349....
Analyst Allen Lutz of Bank of America Securities maintained a Sell rating on Hims & Hers Health, retaining the price target of $32.00. Meet Your ETF AI Analyst...
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
Novo Nordisk A/S (NYSE:NVO) announced on Monday that Wegovy (semaglutide) injection 0.25 mg and 0.5 mg and Ozempic are now available at a limited-time price of...
The stock of pharmaceutical company Eli Lilly (LLY) is down 1% on Nov. 17 after news broke that rival Novo Nordisk (NVO) has lowered the direct-to-consumer pric...
Newly installed Chairperson Lars Rebien Sorensen signaled a rapid shift in governance and strategic direction at Novo Nordisk A/S (NYSE:NVO) , saying he intends...
